GB1321541A - Sulphaguanidine derivatives - Google Patents
Sulphaguanidine derivativesInfo
- Publication number
- GB1321541A GB1321541A GB3025571A GB3025571A GB1321541A GB 1321541 A GB1321541 A GB 1321541A GB 3025571 A GB3025571 A GB 3025571A GB 3025571 A GB3025571 A GB 3025571A GB 1321541 A GB1321541 A GB 1321541A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- marek
- alkylthio
- june
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/95—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
1321541 Treating marek's disease MERCK & CO Inc 28 June 1971 [30 June 1970] 30255/ 71 Heading A5B [Also in Division C2] Pharmaceutical preparations especially suitable for treating or preventing Marek's disease occurring in poultry contain (I), (II), (III) and/or (IV) as active ingredient where Z signifies R 1 CH=N-, R 2 CONH- or (R 3 )(R 4 )(R 6 ). C.NH-, R 1 is phenyl containing F or alkylthio, or Cl and OH substituents or is a 5 or 6-membered ring heterocycle having 1 or 2 heteroatoms, R 2 is C 3 to 6 cycloalkyl, C 10 to 20 alkyl, CF 3 , a 5 or 6-membered ring heterocycle containing 1 heteroatom, alkoxy, haloalkoxy, alkoxyalkoxy or alkylthio, R 3 is NaSO 2 -, HO 2 C-CH 2 -S-, HO 2 C-CH (NHCOMe)CH 2 -S-, CH 3 COCH= or a radical (V), R 4 is H, alkyl or alkoxy, R 5 is H or alkyl and R 6 is H (R 6 is not present when R 3 is attached to C via a double bond). The preparations may be in the form of a feed, supplement, parenterally administrable solution, suspension or dispersion and may also contain nutrients and other additives, e.g. coccidiostats such as amprolium, ethopabate, nicarbazin and 1-(2-n-propyl-4-amino-5-pyridiminylmethyl)-2-methyl pyridinium chloride hydrochloride.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5134270A | 1970-06-30 | 1970-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1321541A true GB1321541A (en) | 1973-06-27 |
Family
ID=21970718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3025571A Expired GB1321541A (en) | 1970-06-30 | 1971-06-28 | Sulphaguanidine derivatives |
Country Status (9)
Country | Link |
---|---|
BE (1) | BE769232A (en) |
CA (1) | CA972366A (en) |
CH (1) | CH558341A (en) |
DE (1) | DE2132306A1 (en) |
ES (1) | ES392602A1 (en) |
FR (1) | FR2100842B1 (en) |
GB (1) | GB1321541A (en) |
NL (1) | NL7108347A (en) |
ZA (1) | ZA714277B (en) |
-
1971
- 1971-06-17 NL NL7108347A patent/NL7108347A/xx unknown
- 1971-06-22 CA CA116,347A patent/CA972366A/en not_active Expired
- 1971-06-24 ES ES392602A patent/ES392602A1/en not_active Expired
- 1971-06-28 GB GB3025571A patent/GB1321541A/en not_active Expired
- 1971-06-29 DE DE19712132306 patent/DE2132306A1/en active Pending
- 1971-06-29 BE BE769232A patent/BE769232A/en unknown
- 1971-06-29 ZA ZA714277A patent/ZA714277B/en unknown
- 1971-06-29 FR FR7123674A patent/FR2100842B1/fr not_active Expired
- 1971-06-29 CH CH955771A patent/CH558341A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES392602A1 (en) | 1974-07-01 |
FR2100842B1 (en) | 1975-02-07 |
FR2100842A1 (en) | 1972-03-24 |
ZA714277B (en) | 1973-02-28 |
DE2132306A1 (en) | 1972-01-05 |
BE769232A (en) | 1971-12-29 |
NL7108347A (en) | 1972-01-03 |
CA972366A (en) | 1975-08-05 |
CH558341A (en) | 1975-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1374823A (en) | Triazolylbenzophenones | |
GB1380129A (en) | Benzofuran derivatives and preparation thereof | |
GB1168738A (en) | Benzimidazole Derivatives and their preparation and use | |
GB1290818A (en) | ||
GB1188846A (en) | Thiazole Derivatives | |
GB1350114A (en) | Anabolic treatment of domestic animals | |
GB1434805A (en) | 5-phenoxy-4-amino pyrimidines | |
GB1321541A (en) | Sulphaguanidine derivatives | |
GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
GB1171670A (en) | Derivatives of 4-Aryl-3-Hydroxybutyric Acid | |
GB1519210A (en) | Antiarrythmic compositions containing pyrrolidinyl derivatives | |
GB1362845A (en) | Benzyl alcohol derivatives | |
GB1252975A (en) | ||
GB1333992A (en) | Method of and compositions for combating mareks disease | |
GB1341339A (en) | Pyridyl thiourea derivatives and preparation thereof | |
GB1169990A (en) | Phenoxy Propan-2-Olamines | |
GB1307256A (en) | Piperazine derivatives and a process for their preparation | |
ATE213648T1 (en) | MEDICINAL PRODUCTS CONTAINING PLATELE AGGREGATION INHIBITORS | |
GB1387803A (en) | Watersoluble salts of polyhydroxyphenylchromanones | |
GB1170860A (en) | Quinoline-3-Carboxylates | |
GB1408984A (en) | Beta-adrenergic blocking aminopropanols | |
GB1354734A (en) | Pharmaceutical compositions comprising aminoguanidine derivatives | |
GB1293691A (en) | TREATMENT OF MAREK'S DISEASE WITH p-AMINO-p'-UREIDODIPHENYL SULFONE | |
GB1314956A (en) | Chromone compounds | |
GB1359044A (en) | Quinoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |